TAGRISSO 40 mg and 80mg film-coated tablets

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Osimertinib Mesylate
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/16/1086/001

40 milligram(s)

L01EB04

Film-coated tablet

EU/1/16/1086/002

80 milligram(s)

L01EB04

Film-coated tablet

EU/1/16/1086/003

40 milligram(s)

L01EB04

Film-coated tablet

EU/1/16/1086/004

80 milligram(s)

L01EB04

Film-coated tablet

Address:
College Business and Technology Park, Blanchardstown Road North, Dublin 15, D15 R925
Medical Information E-mail:
mipqc.ireland@astrazeneca.com
Telephone:
+353 1 609 7100
Fax:
+353 1 686 5038
Website:
https://contactazmedical.astrazeneca.com
Medical Information Direct Line:
1800800899

Address: